Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study

被引：0
|
作者：
Plachta-Danielzik, S. [1 ]
Bokemeyer, B. [1 ,2 ,3 ]
Efken, P. [4 ]
Mohl, W. [5 ]
Hoffstadt, M. [6 ]
Krause, T. [7 ]
Schweitzer, A. [8 ]
Schnoy, E. [9 ]
Ehehalt, R. [10 ]
Trentmann, L. [11 ]
Teich, N. [12 ]
Atreya, R. [13 ]
Franzenburg, S. [1 ]
Hartmann, P.
Wenske, T. [1 ]
Schreiber, S. [1 ]
机构：
[1] Competence Network IBD, Study Dept, Kiel, Germany
[2] Interdisciplinary Crohn Colitis Ctr Minden, Crohn Colitis Ctr, Minden, Germany
[3] Univ Hosp Schleswig Holstein Campus Kiel, Clin Gen Internal Med 1, Kiel, Germany
[4] Gastroenterol Practice Minden, Minden, Germany
[5] Ctr Gastroenterol Saar MVZ, Saarbrucken, Germany
[6] Gastroenterol Practice Iserlohn, Iserlohn, Germany
[7] Gastroenterol Practice Kassel, Kassel, Germany
[8] Gastroenterol Practice Muenster, Munster, Germany
[9] Univ Hosp Augsburg, III Med Clin, Augsburg, Germany
[10] Gastroenterol Practice Heidelberg, Heidelberg, Germany
[11] Gastroenterol Practice Bremen, Bremen, Germany
[12] Gastroenterol Practice Leipzig, Leipzig, Germany
[13] Friedrich Alexander Univ Erlangen Nuernberg, Med Clin 1, Erlangen, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P784
引用
收藏
页码：918 / 919
页数：2
相关论文
共 50 条
  • [31] Effectiveness and Safety of Vedolizumab in Biologic-Naive Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
    Macaluso, F.
    Fries, W.
    Renna, S.
    Viola, A.
    Muscianisi, M.
    Cappello, M.
    Guida, L.
    Siringo, S.
    Camilleri, S.
    Garufi, S.
    Privitera, A. C.
    Belluardo, N.
    Giangreco, E.
    Bertolami, C.
    Vassallo, R.
    Rizzuto, G.
    Orlando, R.
    Ventimiglia, N.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S333 - S333
  • [32] The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
    Eric J. Shiuey
    Nikki A. Mehran
    Melih Ustaoglu
    Qiang Zhang
    Reza Razeghinejad
    Aakriti G. Shukla
    Natasha N. Kolomeyer
    Jonathan S. Myers
    Daniel Lee
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 967 - 974
  • [33] The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
    Shiuey, Eric J.
    Mehran, Nikki A.
    Ustaoglu, Melih
    Zhang, Qiang
    Razeghinejad, Reza
    Shukla, Aakriti G.
    Kolomeyer, Natasha N.
    Myers, Jonathan S.
    Lee, Daniel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (03) : 967 - 974
  • [34] Real-World Effectiveness of Advanced Therapies on Bowel Urgency in Patients With Ulcerative Colitis in the United States: Results from SPARC IBD
    Lewis, James
    Chan, Wai Man Maria
    Moses, Richard E.
    Zhou, Xian
    Wang, Yitong
    Gibble, Theresa Hunter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S688 - S689
  • [35] REAL-WORLD EFFECTS OF BECLOMETHASONE DIPROPIONATE NASAL AEROSOL IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS: 6-MONTH RESULTS
    Bukstein, D.
    Parikh, R.
    Eid, S.
    Ferro, T.
    Morello, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A116 - A117
  • [36] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB VS. INFLIXIMAB INDUCTION THERAPY IN ULCERATIVE COLITIS: EXPERIENCE OF A REAL-WORLD COHORT AT A TERTIARY IBD CENTER
    Allamneni, Chaitanya
    Venkata, Krishna
    Xie, Fenglong
    DeLoach, Lindsey
    Malik, Talha
    GASTROENTEROLOGY, 2018, 154 (01) : S72 - S72
  • [37] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB VS. INFLIXIMAB INDUCTION THERAPY IN ULCERATIVE COLITIS: EXPERIENCE OF A REAL-WORLD COHORT AT A TERTIARY IBD CENTER
    Allamneni, Chaitanya
    Venkata, Krishna
    Xie, Fenglong
    DeLoach, Lindsey
    Malik, Talha
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S49 - S50
  • [38] EFFECTIVENESS OF VEDOLIZUMAB ON INTESTINAL AND ARTICULAR OUTCOMES: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
    Macaluso, F. S.
    Orlando, R.
    Fries, W.
    Scolaro, M.
    Magnano, A.
    Pluchino, D.
    Cappello, M.
    Morreale, G. C.
    Siringo, S.
    Privitera, A. C.
    Ferracane, C.
    Belluardo, N.
    Alberghina, N.
    Ventimiglia, M.
    Rizzuto, G.
    Renna, S.
    Cottone, M.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E133 - E134
  • [39] TREATMENT DISCONTINUATION, FLARES, AND HOSPITALIZATIONS AMONG BIOLOGIC-NAiVE PATIENTS WITH IBD OVER THE FIRST YEAR OF TREATMENT: A "REAL-WORLD" COMPARATIVE EFFECTIVENESS STUDY OF VEDOLIZUMAB VERSUS INFLIXIMAB
    Patel, Haridarshan
    Raluy-Callado, Mireia
    Berger, Ariel
    Curtis, Rebecca
    Khalid, Javaria Mona
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S78 - S79
  • [40] EFFECTIVENESS AND SAFETY OUTCOMES BEYOND FIVE YEARS OF IBD PATIENTS TREATED WITH VEDOLIZUMAB. THE LONGLIVE IG-IBD STUDY
    Privitera, G.
    Pugliese, D.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S114 - S114
12345